Genetically Predicted Circulating Level of C-Reactive Protein Is Not Associated With Prostate Cancer Risk
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genetically Predicted Circulating Level of C-Reactive Protein Is Not Associated With Prostate Cancer Risk
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-10-14
DOI
10.3389/fonc.2020.545603
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inflammatory serum markers and risk and severity of prostate cancer: The PROCA‐ life study
- (2019) Einar Stikbakke et al. INTERNATIONAL JOURNAL OF CANCER
- Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS study
- (2018) R. Arthur et al. INTERNATIONAL JOURNAL OF CANCER
- Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases
- (2018) Marie Verbanck et al. NATURE GENETICS
- Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
- (2018) Fredrick R. Schumacher et al. NATURE GENETICS
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders
- (2018) Symen Ligthart et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator
- (2016) Jack Bowden et al. GENETIC EPIDEMIOLOGY
- The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog)
- (2016) Jacqueline MacArthur et al. NUCLEIC ACIDS RESEARCH
- Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression
- (2015) J. Bowden et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- An epidemiological analysis of potential associations between C-reactive protein, inflammation, and prostate cancer in the male US population using the 2009–2010 National Health and Nutrition Examination Survey (NHANES) data
- (2015) Catherine A. St. Hill et al. Frontiers in Chemistry
- Prevention and early detection of prostate cancer
- (2014) Jack Cuzick et al. LANCET ONCOLOGY
- Association Between C-reactive Protein and Risk of Cancer: A Meta-analysis of Prospective Cohort Studies
- (2013) Yong-Zhong Guo et al. Asian Pacific Journal of Cancer Prevention
- Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data
- (2013) Stephen Burgess et al. GENETIC EPIDEMIOLOGY
- Association Between Prediagnostic Biomarkers of Inflammation and Endothelial Function and Cancer Risk: A Nested Case-Control Study
- (2012) M. Touvier et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Avoiding bias from weak instruments in Mendelian randomization studies
- (2011) Stephen Burgess et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- C-reactive protein as a biomarker for urological cancers
- (2011) Kazutaka Saito et al. Nature Reviews Urology
- Risk of prostate cancer is not associated with levels of C-reactive protein and other commonly used markers of inflammation
- (2010) Mieke Van Hemelrijck et al. INTERNATIONAL JOURNAL OF CANCER
- C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older
- (2009) Brandon L. Pierce et al. CANCER CAUSES & CONTROL
- Circulating prediagnostic interleukin-6 and C-reactive protein and prostate cancer incidence and mortality
- (2008) Jennifer Rider Stark et al. INTERNATIONAL JOURNAL OF CANCER
- Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology
- (2007) Debbie A. Lawlor et al. STATISTICS IN MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started